357 related articles for article (PubMed ID: 19089973)
1. Conserved amino acid networks involved in antibody variable domain interactions.
Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973
[TBL] [Abstract][Full Text] [Related]
2. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
Narayanan A; Sellers BD; Jacobson MP
J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
[TBL] [Abstract][Full Text] [Related]
3. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
Jespers L; Schon O; James LC; Veprintsev D; Winter G
J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
[TBL] [Abstract][Full Text] [Related]
5. A novel antibody AA98 V(H)/L directed against CD146 efficiently inhibits angiogenesis.
Lin Y; Wu X; Shen Y; Bu P; Yang D; Yan X
Anticancer Res; 2007; 27(6B):4219-24. PubMed ID: 18225593
[TBL] [Abstract][Full Text] [Related]
6. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED
J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998
[TBL] [Abstract][Full Text] [Related]
8. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
9. Lack of promiscuity in autoantigen-specific H and L chain combinations as revealed by human H and L chain "roulette".
Portolano S; Chazenbalk GD; Hutchison JS; McLachlan SM; Rapoport B
J Immunol; 1993 Feb; 150(3):880-7. PubMed ID: 8423344
[TBL] [Abstract][Full Text] [Related]
10. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
[TBL] [Abstract][Full Text] [Related]
11. Three monoclonal antibodies to the VHS virus glycoprotein: comparison of reactivity in relation to differences in immunoglobulin variable domain gene sequences.
Lorenzen N; Cupit PM; Secombes CJ; Cunningham C
Fish Shellfish Immunol; 2000 Feb; 10(2):129-42. PubMed ID: 10938729
[TBL] [Abstract][Full Text] [Related]
12. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.
de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T
J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421
[TBL] [Abstract][Full Text] [Related]
13. Intrabody construction and expression III: engineering hyperstable V(H) domains.
Wirtz P; Steipe B
Protein Sci; 1999 Nov; 8(11):2245-50. PubMed ID: 10595527
[TBL] [Abstract][Full Text] [Related]
14. [Cloning and sequence analysis of variable region gene of anti-idiotype monoclonal antibody against Vibrio alginolyticus].
Fu JF; Huang WQ; Xia YJ; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):57-9. PubMed ID: 15629085
[TBL] [Abstract][Full Text] [Related]
15. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach.
Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R
Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398
[TBL] [Abstract][Full Text] [Related]
16. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
Li J; Geissal ED; Li W; Stollar BD
Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
[TBL] [Abstract][Full Text] [Related]
17. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
18. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
[TBL] [Abstract][Full Text] [Related]
19. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
20. Disulfide linkage engineering for improving biophysical properties of human VH domains.
Kim DY; Kandalaft H; Ding W; Ryan S; van Faassen H; Hirama T; Foote SJ; MacKenzie R; Tanha J
Protein Eng Des Sel; 2012 Oct; 25(10):581-9. PubMed ID: 22942392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]